Meta-analysis suggests Hatha yoga may improve blood pressure and glucose in non-communicable disease patients
Simple Yoga Moves Could Help Manage Heart Disease Risks
This meta-analysis evaluated Hatha yoga interventions in patients diagnosed with non-communicable diseases including Type 2 Diabetes and hyp…
Adding yoga to your daily routine may lower blood pressure and blood sugar for people with sedentary lifestyles and heart risks.
Meta-analysis of dapagliflozin for renal outcomes in type 2 diabetes and CKD
SGLT2 inhibitors lower kidney failure risk in type 2 diabetes patients
This systematic review and meta-analysis of 10 studies synthesized evidence on dapagliflozin for renal outcomes in patients with type 2 diab…
A review of ten studies shows these drugs reduce kidney failure risk in people with type 2 diabetes and kidney disease.
Telemedicine applications in general practice show positive clinical outcomes for chronic diseases
New review shows telemedicine works well for chronic illness
This structured review of 22 studies, primarily RCTs, evaluated telemedicine applications for patients with chronic somatic diseases in gene…
New evidence suggests telemedicine is safe and effective for managing chronic conditions like diabetes and heart disease.
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models
How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
This narrative review synthesizes evidence from human studies, animal models, and in vitro experiments regarding microgravity and metabolic …
This research shows that the same health problems astronauts face in space are happening to people on Earth who sit too much, and it may lea…
Metformin use in Type 2 Diabetes shows inconsistent clinical effects in review
Metformin Does More Than Lower Blood Sugar For Your Health
This review examines metformin in over 150 million individuals worldwide receiving treatment annually for Type 2 Diabetes.
Metformin might be doing much more than just controlling blood sugar for people with diabetes.
Meta-analysis of sex differences in insulin therapy outcomes for adults with Type 1 and Type 2 diabetes
Women and Men Respond Differently to Insulin Therapy
This systematic review and meta-analysis evaluated sex differences in insulin therapy outcomes across 24 studies involving adults with Type …
Maria takes insulin every day for type 2 diabetes.
Meta-analysis links genetic variants to gestational diabetes mellitus risk in British, Finnish, and Chinese populations
New genes linked to gestational diabetes risk identified
This meta-analysis synthesizes GWAS data regarding genetic variants associated with gestational diabetes mellitus and Type 2 Diabetes.
Two newly discovered genes, ELL2 and ATRAID, may increase risk for gestational diabetes, offering clues for future treatments.
Higher ZJU index associated with worse metabolic profiles in adults with type 2 diabetes and hyperuricemia
High Uric Acid in Diabetes? Check This One Number First
This retrospective cross-sectional analysis of 1772 adults with type 2 diabetes mellitus evaluated the association between the Zhejiang Univ…
A simple calculation used for liver health may also warn about uric acid problems in diabetes.
Observational review of layered data models improves DKD risk detection in type 2 diabetes cohorts
Better tools found to spot kidney disease risk in people with type 2 diabetes
This observational review synthesizes findings from the All of Us Research Program and BioMe Biobank regarding DKD risk detection.
New analysis suggests layered health data can improve detection of diabetic kidney disease, helping catch cases earlier in people with type …
Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study
Tirzepatide Saves Money and Health Over Semaglutide
This simulation modeling study using Phase-3 trial data evaluated tirzepatide versus semaglutide in individuals with obesity or overweight w…
Imagine standing in a doctor's office, facing a choice between two powerful weight-loss medicines.
Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT
Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes.
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.
Higher Geriatric Nutritional Risk Index linked to lower osteoporosis risk in diabetic women
Better nutrition linked to lower osteoporosis risk in women with diabetes
This retrospective observational cohort study of 324 postmenopausal women with type 2 diabetes found that a higher Geriatric Nutritional Ris…
A simple nutrition score may help spot osteoporosis risk in women with type 2 diabetes, new hospital data suggests.